US STOCK
AXSM Stock Analysis
US stocks · market data · technical indicators
Axsome Therapeutics, Inc.
AXSMUS stocksQuote delayed 15 min
10/26 上午10:22 updated
$145.04
-11.03-7.07%
Open
$154.66
High
$154.74
Low
$143.90
Volume
159.37萬
AXSM price history
-25.19%Open
193.89
Latest
145.04
High
193.89
Low
145.04
Average
168.24
Advertisement
Financial snapshot
AXSM - Axsome Therapeutics, Inc.
EPS
-3.74USD
Forward EPS
3.69USD
P/E
--
Forward P/E
39.27x
P/B
91.05x
ROE
-245.10%
ROA
-16.31%
Operating margin
-23.42%
Profit margin
-24.68%
Revenue growth
45.50%
Earnings growth
--
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $218.38M | $191.20M | $196.00M | $170.99M | $150.04M |
| Gross profit | $204.81M | $176.48M | $183.67M | $159.08M | $136.59M |
| Operating income | -$51.14M | -$62.77M | -$36.02M | -$32.92M | -$44.82M |
| Net income | -$51.31M | -$64.54M | -$28.56M | -$47.23M | -$47.97M |
| Basic EPS | -0.99 | -1.26 | -0.56 | -0.94 | -0.97 |
| Diluted EPS | -0.99 | -1.26 | -0.56 | -0.94 | -0.97 |
Estimates vs actuals
Next earnings
2026-11-02
EPS estimate
-0.64
Revenue estimate
$250.19M
Last surprise
-26.85%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-02 | -0.64 | Not reported | — |
| 2026-08-10 | -0.78 | -0.99 | -26.85% |
| 2026-05-04 | -0.86 | -1.26 | -46.03% |
| 2026-02-23 | -0.73 | -0.56 | +23.63% |
| 2025-11-03 | -0.90 | -0.94 | -4.19% |
| 2025-08-04 | -1.09 | -0.97 | +10.75% |
| 2025-05-05 | -1.35 | -1.22 | +9.51% |
| 2025-02-18 | -1.05 | -1.54 | -47.03% |
| 2024-11-12 | -1.39 | -1.34 | +3.49% |
| 2024-08-05 | -1.33 | -1.67 | -25.84% |
| 2024-05-06 | -1.22 | -1.44 | -17.65% |
| 2024-02-20 | -1.19 | -2.08 | -74.83% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $760.7M | 0.01% |
| BlackRock Inc. | 2024-06-30 | $265.6M | 0.01% |
| STATE STREET CORP | 2026-06-30 | $192.3M | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $163.9M | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $64.1M | 0.09% |
| CITADEL ADVISORS LLC | 2026-06-30 | $62.6M | 0.01% |
| Bridgewater Associates, LP | 2026-06-30 | $14.2M | 0.06% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$280.33
Target range
$245.00 – $380.00
Implied upside
93.28%
Strong buy
3
Buy
18
Hold
1
Sell
0
Strong sell
0
Advertisement